Peng Liu

7.0k citations
178 papers · 4.0k indexed · 1 hit paper · h-index 32
Topics
Immunotherapy and Immune Responses (20 papers)Cancer Immunotherapy and Biomarkers (15 papers)Immune Cell Function and Interaction (13 papers)
Journals
SHILAP Revista de lepidopterologíaThe EMBO JournalBlood
Partner nations
ChinaFranceSweden

In The Last Decade

Peng Liu

166 papers receiving 3.9k citations

Hit Papers

Detection of immunogenic cell death and its relevance for...20202026202220242020250500750

Peers

Peng Liu
Comparison fields: 5 of 152
  • Molecular Biology 1.3k
  • Immunology 1.1k
  • Oncology 1.1k
  • Biomedical Engineering 552
  • Epidemiology 451
Replace Zhihua Chen with:
Zhihua Chen China
Hamed Mohammadi Iran
Lei Fang China
Qing Miao China
Yusuf Baran Türkiye
Ligong Lu China
Dianwen Ju China
Zhao Huang China
Min Zhang China
Xueying Sun China
Peng Liu relative to Zhihua Chen China Zhihua Chen's profile →
Citations per field
00.5×4.3×
Zhihua Chen · 1×
Citations per year

Countries citing papers authored by Peng Liu

Since Specialization
Citations

This map shows the geographic impact of Peng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Liu more than expected).

Fields of papers citing papers by Peng Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Liu. The network helps show where Peng Liu may publish in the future.

Co-authorship network of co-authors of Peng Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Liu. A scholar is included among the top collaborators of Peng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Liu. Peng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 1
3 2
4 3
5 3
6 3
7 0
8 4
9 6
10 8
11 3
12 7
13 23
14 4
15 16
16 14
17 7
18 23
19 1
20 69

About Peng Liu

Peng Liu is a scholar working on Immunology, Oncology and Molecular Medicine, having authored 178 papers that have together received 4.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (20 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Immune Cell Function and Interaction (13 papers). The work is most often cited by research in Immunology (1.1k citations), Oncology (1.1k citations) and Physiology (156 citations). Peng Liu has collaborated with scholars based in China, France and Sweden. Frequent co-authors include Oliver Kepp, Guido Kroemer, Liwei Zhao, Takahiro Yamazaki, Lenka Kašíková, Radek Špíšek, Jitka Fučíková, Lorenzo Galluzzi, Giulia Petroni and Laurence Zitvogel. Their work appears in journals such as SHILAP Revista de lepidopterología, The EMBO Journal and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026